Co-encapsulation of norcantharidin prodrugs and lomitapide in nanoparticles to regulate CCL4 expression by inhibiting Wnt/β-catenin pathway for improved anti-tumor immunotherapy | Journal of Nanobiotechnology
Synergistic induction of robust CCL4 production via β-Catenin suppression by “NCTD + lomi” synergism Despite the exponential increase in studies using nanocarriers to co-deliver drug combinations since 1999 , most research based…